Sandra Levy
ARTICLES BY THIS AUTHOR
- 2/17/2020
Generics companies expand scope, capabilities to fight headwinds
At a time when people expect negative news in the generics industry, many generics firms are managing to thrive. - 2/17/2020
Lupin launches generic Moxeza
Moxifloxacin ophthalmic solution had a market value of approximately $10 million, according to IQVIA December 2019 data. - 2/17/2020
QS/1, Integra plan inaugural iQ Conference
The first-ever iQ Conference will feature a wide range of educational topics, products, and speakers. - 2/17/2020
IQVIA's Long sizes up generics market
Three trends are driving the generics market, according to IQVIA vice president of industry relations Doug Long. - 2/17/2020
Geneyork debuts generic Deltasone
Prednisone tablets had a market value of $121 million for 2018, according to IQVIA. - 2/13/2020
Benzer Pharmacy launches at-home medication disposal program
Benzer Pharmacy is introducing an at-home medication disposal program, which uses DisposeRx packets. - 2/13/2020
NACDS’ Anderson cites Harvard Business Review article to advance roles of pharmacists, techs
NACDS' president and CEO Steve Anderson's opinion piece on Medium cites an article in the Harvard Business Review that underscores the role of pharmacists in patient care. - 2/12/2020
Zydus Cadila gets FDA OK for 2 generics
Patients with a certain type of bowel disease, and those with various skin conditions, have new generic treatment options from Zydus Cadila. - 2/11/2020
CVS Health makes Caremark transformation leadership appointments
CVS Health's new leadership team appointments are aimed at continuing its transformation in the way care is provided. - 2/11/2020
CVS Health posts strong Q4
CVS Health's fourth-quarter and full-year results spotlighted growth in its retail pharmacy/long-term care segment driven, largely by increased prescription volume.
